文献速递创伤骨科小儿骨科

肢体延长术后住院时间与再入院率的相关因素:一项大型数据库研究

What Factors Correlate With Length of Stay and Readmission After Limb Lengthening Procedures? A Large-database Study.
PubMed 文献 · Clin Orthop Relat Res · 2022-03-30

该研究利用2005至2015年七州HCUP州住院数据库,分析3488例股骨或胫骨延长术患者,中位住院时间为3天(2至4天),1年再入院率为35%(1237/3488);成人、政府保险及外固定或混合固定患者再入院风险更高。

要点

  • 肢体延长术中位住院时间为3天(IQR 2至4天),多变量模型解释力低(R²=0.03),未能得出有意义的相关性。
  • 1年再入院率为35%(1237/3488);成人较儿童再入院风险高(OR 1.78 [95%CI 1.46至2.18];p<0.001)。
  • 政府保险较商业保险再入院风险高(OR 1.28 [95%CI 1.05至1.54];p=0.01);外固定(OR 1.61 [95%CI 1.29至2.02];p<0.001)或混合固定(OR 1.81 [95%CI 1.38至2.37];p<0.001)较单纯内固定再入院风险高。

核心结论

  • 作者认为,临床医生可依据本研究结果向肢体延长候选患者及其照护者告知预期住院时间和再入院可能性。
  • 作者建议告知成人患者、政府保险患者以及接受混合或外固定架肢体延长的患者,其再入院风险更高。
  • 作者指出,特定患者相关因素(如畸形严重程度或合并症)和治疗相关变量(如延长量、物理治疗依从性或外科医生经验)与临床结局及再入院负担的关系需进一步研究。

研究设计与样本

  • 利用2005至2015年七州医疗成本与利用项目(HCUP)州住院数据库,识别基于ICD-9手术编码的股骨和/或胫骨延长住院病例。
  • 共识别3979例住院病例,排除2%(97/3979)因主或翻修髋或膝关节置换术ICD-9编码的病例,排除10%(394/3979)因数据库内既往住院数据的重复入院病例,最终分析3488例患者。
  • 患者中位(四分位距)年龄18岁(12至41岁),女性占42%(1481/3488);49%(1705/3469)为儿童(小于18岁),19%(675/3469)为年轻成人(18至34岁),24%(817/3469)为成人(35至59岁),8%(272/3469)为老年人(60岁及以上)。
  • 计算延长术后住院时间和1年再入院率;采用单变量分析检验年龄、种族、支付方式、基础诊断、延长骨段和延长技术与住院时间及再入院率的关联;对与结局变量显著相关(p<0.05)的因素进一步行多变量分析。
  • 证据等级为III级,治疗性研究。

主要发现

  • 纳入患者的中位(IQR)住院时间为3天(2至4天)。
  • 多变量模型对住院时间的解释力差(R²=0.03),未能得出年龄、种族、基础诊断、延长技术与住院时间之间的有意义相关性。
  • 总体1年再入院率为35%(1237/3488)。
  • 成人患者再入院率高于儿童患者(OR 1.78 [95%CI 1.46至2.18];p<0.001)。
  • 政府保险患者再入院率高于商业保险患者(OR 1.28 [95%CI 1.05至1.54];p=0.01);外固定延长(OR 1.61 [95%CI 1.29至2.02];p<0.001)或混合固定延长(OR 1.81 [95%CI 1.38至2.37];p<0.001)患者再入院率高于单纯内固定延长患者。

关键数值与推荐

  • 成人较儿童再入院风险高:OR 1.78(95%CI 1.46至2.18;p<0.001)。
  • 政府保险较商业保险再入院风险高:OR 1.28(95%CI 1.05至1.54;p=0.01)。
  • 外固定较单纯内固定再入院风险高:OR 1.61(95%CI 1.29至2.02;p<0.001)。
  • 混合固定较单纯内固定再入院风险高:OR 1.81(95%CI 1.38至2.37;p<0.001)。
  • 住院时间多变量模型R²=0.03。

临床怎么用

  • 作者认为,临床医生可依据本研究结果向肢体延长候选患者及其照护者告知预期住院时间和再入院可能性。
  • 作者建议告知成人患者、政府保险患者以及接受混合或外固定架肢体延长的患者,其再入院风险更高。
  • 作者指出,特定患者相关因素和治疗相关变量与临床结局及再入院负担的关系需进一步研究。

局限性

  • 作者指出,多变量模型对住院时间的解释力差(R²=0.03),未能得出有意义的相关性。
  • 作者指出,特定患者相关因素(如畸形严重程度或合并症)和治疗相关变量(如延长量、物理治疗依从性或外科医生经验)与临床结局及再入院负担的关系需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indications and techniques for limb lengthening procedures have evolved over the past two decades. Although there are several case series reporting on the complications and efficacy of these techniques, limited data are available on length of stay and hospital readmission rates after these procedures. QUESTIONS/PURPOSES: (1) What is the median length of stay after lower limb lengthening procedures, and is variability in patient demographics, preoperative diagnosis, and surgical technique associated with length of stay? (2) What is the 1-year readmission rate after lower limb lengthening procedures? (3) Is variability in patient demographics, preoperative diagnosis, and surgical technique associated with varying rates of hospital readmission? METHODS: Patients who underwent femoral or tibial lengthening from 2005 to 2015 in seven states were identified using the Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases. These databases include a large, diverse group of patients across a wide range of hospitals and socioeconomic backgrounds with inclusion of patients regardless of payer. Between 2005 and 2015, there were 3979 inpatient admissions that were identified as involving femoral and/or tibial lengthening procedures based on ICD-9 procedure codes; of those, 2% (97 of 3979) of the inpatient admissions were excluded from analysis because they had ICD-9 procedure codes for primary or revision hip or knee arthroplasty, and 10% (394 of 3979) of the inpatient admissions were excluded because they involved repeated admissions of patients with previous hospitalization data within the database. This yielded 3488 patients for analysis. The median (interquartile range) age of patients was 18 years (12 to 41), and 42% (1481 of 3488) of patients were women. A total of 49% (1705 of 3469) of patients were children (younger than 18 years), 19% (675 of 3469) were young adults (18 to 34 years), 24% (817 of 3469) were adults (35 to 59 years), and 8% (272 of 3469) were seniors (60 years and older). Length of stay and rates of readmission at 1 year after the lengthening procedure were calculated. Univariate analysis was performed to examine associations between age, race, payment method, underlying diagnosis, bone lengthened, and lengthening technique with length of stay and readmission rate. Factors found to be significantly associated with the outcome variables (p < 0.05) were further examined with a multivariate analyses. RESULTS: Included patients had a median (IQR) length of hospital stay of 3 days (2 to 4). Given the poor explanatory power of the multivariate model for length of stay (R 2 = 0.03), no meaningful correlations could be drawn between age, race, underlying diagnosis, lengthening technique, and length of stay. The overall 1-year readmission rate was 35% (1237 of 3488). There were higher readmission rates among adult patients compared with pediatric patients (odds ratio 1.78 [95% confidence interval 1.46 to 2.18]; p < 0.001), patients with government insurance compared with commercial insurance (OR 1.28 [95% CI 1.05 to 1.54]; p = 0.01), and patients undergoing lengthening via external fixation (OR 1.61 [95% CI 1.29 to 2.02]; p < 0.001) or hybrid fixation (OR 1.81 [95% CI 1.38 to 2.37]; p < 0.001) compared with lengthening with internal fixation only. CONCLUSION: When counseling patients who may be candidates for limb lengthening, providers should inform individual patients and their caretakers on the anticipated length of hospital stay and likelihood of hospital readmission based on our findings. Adult patients, those with government insurance, and patients undergoing hybrid or external fixator limb lengthening procedures should be advised that they are at greater risk for hospital readmission. The relationship of specific patient-related factors (such as severity of deformity or associated comorbidities) and treatment-related variables (such as amount of lengthening, compliance with physical therapy, or surgeon's experience) with clinical outcomes after lower limb lengthening and the burden of care associated with hospital readmission needs further study. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Mittal A, Allahabadi S, Jayaram R, et al. What Factors Correlate With Length of Stay and Readmission After Limb Lengthening Procedures? A Large-database Study. Clin Orthop Relat Res. 2022. PMID: 35353078. doi:10.1097/CORR.0000000000002201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。